HB
Hemin Bhaskarbhai Patel
About Hemin Bhaskarbhai Patel
Data last updated:
Hemin Bhaskarbhai Patel is a Director at Biopin Healthcare Private Limited (since 2021), Designated Partner at Satvam Estate Three Llp (since 2025) and Director at Intellysis Digital Private Limited (since 2025), and holds 1 more current directorship. The companies operate in Pharma and Infrastructure. The largest current company by reported revenue is Biopin Healthcare Private Limited at ₹1.95 Cr (FY 2025). Earlier, Hemin Bhaskarbhai Patel was a Director at Centurion Remedies Private Limited (2015–2023) and Additional Director at Centurion Laboratories Private Limited (2017) and 1 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Biopin Healthcare Private Limited U24110GJ2021PTC121287 | Director | 17 Mar 2021 | 2021 | ₹1.95 Cr (FY 2025) | Active |
| Satvam Estate Three Llp ACM-5639 | Designated Partner | 11 Mar 2025 | 2025 | Active | |
| Intellysis Digital Private Limited U62099GJ2025PTC158054 | Director | 20 Jan 2025 | 2025 | Active | |
| Curventis Laboratories Llp AAM-1114 | Designated Partner | 26 Feb 2018 | 2018 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Centurion Remedies Private Limited U24231GJ2003PTC042254 | Director | 02 Feb 2015 | 2003 | ₹128 Cr (FY 2025) | Active |
 Centurion Laboratories Private Limited U73100GJ2006PTC049620 | Additional Director | 25 Jan 2017 | 2006 | ₹208 Cr (FY 2024) | Active |
| Paperwood Hotels Private Limited U55101GJ2011PTC068389 | Director | 06 May 2013 | 2011 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Hemin Bhaskarbhai Patel
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ronakkumar Harishbhai Patel | 09111237 | Biopin Healthcare Private Limited | Director |
| Punit Bhaskarbhai Patel | 05133077 | Satvam Estate Three Llp | Designated Partner |
| Mankad Nihar Sanatkumar | 02034601 | Intellysis Digital Private Limited | Director |
| Prashant Patel | 10913661 | Intellysis Digital Private Limited | Director |
| Punkil Jitendrabhai Patel | 10913660 | Intellysis Digital Private Limited | Director |
| Mahipat Ambalalbhai Patel | 06373494 | Curventis Laboratories Llp | Designated Partner |
| Sodanin Saing | 08042151 | Curventis Laboratories Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Hemin Bhaskarbhai Patel
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Hemin Bhaskarbhai Patel
Hemin Bhaskarbhai Patel currently holds 4 directorships: Biopin Healthcare Private Limited (Director, since 17 Mar 2021, revenue ₹1.95 Cr (FY 2025)); Satvam Estate Three Llp (Designated Partner, since 11 Mar 2025); Intellysis Digital Private Limited (Director, since 20 Jan 2025); Curventis Laboratories Llp (Designated Partner, since 26 Feb 2018).
Hemin Bhaskarbhai Patel was first appointed on 06 May 2013 as Director at Paperwood Hotels Private Limited. The most recent appointment on record is 11 Mar 2025 at Satvam Estate Three Llp.
Hemin Bhaskarbhai Patel held 3 earlier board appointments: Centurion Remedies Private Limited (Director, 02 Feb 2015 to 29 Apr 2023); Centurion Laboratories Private Limited (Additional Director, 25 Jan 2017 to 30 Sep 2017); Paperwood Hotels Private Limited (Director, from 06 May 2013).
The current boards of Hemin Bhaskarbhai Patel's companies include Ronakkumar Harishbhai Patel (Biopin Healthcare Private Limited), Punit Bhaskarbhai Patel (Satvam Estate Three Llp), Mankad Nihar Sanatkumar (Intellysis Digital Private Limited), Prashant Patel (Intellysis Digital Private Limited), Punkil Jitendrabhai Patel (Intellysis Digital Private Limited), Mahipat Ambalalbhai Patel (Curventis Laboratories Llp), among others.